Hepatitis C patients have been protesting for past one week outside India’s patent office in Dwarka against Gilead Sciences and the United States government for forcing the Indian government “to blindly and speedily grant patents”. IPO is in the process of hearing the company’s patent claim on the drug Sovaldi, with an astounding price of $84,000 (about Rs.57 lakh) in the U.S [more].
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
bottom of page
Comentários